文献速递血液净化与透析

透析中低血压发作仅偶尔伴随不良症状

Intradialytic Hypotensive Episodes are Only Occasionally Associated With Adverse Symptoms.
PubMed 文献 · Kidney Int Rep · 2025-12-12

该研究为HOLLANT试验的二次分析,纳入40例维持性血液透析或血液透析滤过患者,比较4种透析模式。结果发现458次治疗中IDH发生率为20.1%,共222次发作,其中98%无症状;实时报告的症状仅5.2%的 session 出现,且仅4次符合阈值标准。IDH与透析中患者报告结局指标(PID-PROMs)基本无关联。

要点

  • 无症状IDH远多于有症状IDH,基于症状的定义严重低估IDH发生率。
  • 实时症状和PID-PROMs与IDH仅偶尔相关,不宜单独作为IDH判定依据。
  • 阈值定义的IDH与症状/患者报告结局关联较弱,临床需综合评估。

核心结论

  • 无症状IDH的发生率远高于有症状IDH,基于症状的定义会严重低估IDH incidence。
  • 实时出现的症状和PID-PROMs仅偶尔与IDH相关。

研究设计与样本

  • HOLLANT研究(随机交叉试验)的二次分析,比较4种透析模式,每种应用2周。
  • 纳入40例 prevalent HD 和 HDF 患者,每种模式第二周每15分钟及出现症状时测量血压。

主要发现

  • 458次治疗中20.1%观察到IDH,共222次发作(0.48次/ session)。
  • 多数IDH发生在透析后期,98%为无症状。
  • 实时报告症状见于5.2%的 session(n=24),其中半数(13/24)与血压相关,仅4次符合阈值标准。
  • IDH与PID-PROMs之间基本无关联。

关键数值与推荐

  • IDH阈值定义:透析前收缩压(SBP)<90 mmHg或<100 mmHg(取决于透析前SBP)。
  • 有症状IDH(sIDH)定义为IDH同时伴有实时症状。

临床怎么用

  • 临床不应仅依赖症状判断IDH,需结合血压阈值监测。
  • 对无症状IDH应保持关注,但PID-PROMs对IDH的提示价值有限。

局限性

  • 为二次分析,样本量40例,结论需在更大队列中验证。
  • 数据来自交叉试验,各模式数据合并分析,可能掩盖模式间差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Although intradialytic hypotension (IDH) is a frequent complication of hemodialysis (HD), a consensus definition is lacking. Adverse symptoms and/or interventions are a prerequisite in guidelines; however, a threshold-based blood pressure (BP) definition appeared most strongly associated with mortality. In this study, we evaluated the association of IDH with both real-time symptoms and physical intradialytic patient-reported outcome measures (PID-PROMs) in prevalent HD and hemodiafiltration (HDF) patients. METHODS: This is a secondary analysis of the HOLLANT study, a randomized cross-over trial comparing 4 dialysis modalities (i.e., standard HD, cool high-flux HD, low-volume HDF, and high-volume HDF), each applied for 2 weeks in 40 patients. In each second treatment week, BP was measured every 15 minutes and when symptoms occurred. Symptoms were documented real-time and PID-PROMs were collected after each modality. Considering that symptoms occurred independent of dialysis mode, data from all treatment modalities were pooled. IDH was threshold-defined (systolic BP [SBP] < 90 or < 100 mm Hg, dependent on predialysis SBP). The incidence of symptomatic IDH (sIDH) and asymptomatic IDH (aIDH) was assessed, with sIDH defined by concurrent symptoms. When real-time symptoms arose, attribution to IDH was appraised according to the threshold, National Kidney Disease Outcomes Quality Initiative, and the European Best Practice Guideline definitions. Differences in PID-PROMs were analyzed in tertiles of IDH occurrence. RESULTS: In 20.1% of 458 treatments, 222 IDH episodes were observed (0.48/session). The majority occurred toward the end of dialysis and 98% was asymptomatic. Real-time reported symptoms (n = 24) were noted in 5.2% of the sessions. Although half were BP-related (n = 13/24), just 4 fulfilled the threshold criteria. Associations between IDH and PID-PROMs were largely absent. CONCLUSION: aIDH exceeds sIDH by far. Therefore, symptom-based definitions severely underestimate aIDH incidence. Both real-time occurring symptoms and PID-PROMs are only occasionally associated with IDH.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Chaara S, Rootjes PA, Bergtop MIY, et al. Intradialytic Hypotensive Episodes are Only Occasionally Associated With Adverse Symptoms. Kidney Int Rep. 2025. PMID: 41684791. doi:10.1016/j.ekir.2025.103718

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。